Accuracy of the HemoCue® to measure cell-free plasma hemoglobin and detect clinically significant hemolysis

Monitoring cell-free plasma hemoglobin (PHb) during extracorporeal therapies allows early intervention of significant hemolysis, but timely measurements are often challenging. We thus present an analysis of a rapid benchtop device's ability to detect clinically significant hemolysis (PHb ≥50 mg...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Perfusion 2024-10, p.2676591241292674
Hauptverfasser:	Butler, Madison, Maywar, Anna, Ruppert, Kristine, Fuhrman, Dana, Kim-Campbell, Nahmah
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!